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For reproductive-age women living with HIV, birth spacing allows for
optimization of maternal health and viral suppression to prevent mother-tochild transmission of HIV. We conducted semi-structured informational
interviews to explore use of contraception for birth spacing. Interviews were
transcribed and analyzed. Audio files were reviewed to capture non-explicit
data. We interviewed 18 multiparous HIV positive women. All described
experiences with at least one contraceptive method. Six themes emerged:
Burden of contraception, Failure of birth control, Impact of youth and lack of
life experience, Community beliefs about birth control, Lack of partner
cooperation, and Altruism. Women viewed birth spacing favorably. Young age
at first delivery, contraceptive side effects, non-adherence to short-acting
methods, lack of partner cooperation, and prior contraceptive failure were
identified as barriers to ideal birth spacing. Additional outreach is needed in
women living with HIV to overcome barriers to planned pregnancy and birth
spacing. Keywords: HIV; Pregnancy Spacing; Birth Spacing; Inter-Pregnancy
Interval; Dual Method; Contraception; Family Planning; Miles, Huberman and
Saldaña Analytic Framework
The optimal inter-pregnancy interval, the time lapse between birth of one child and
subsequent conception, is at least 24 months (World Health Organization, 2005). Although
much of the literature on pregnancy intervals is older, shorter inter-pregnancy intervals have
been consistently associated with poorer maternal outcomes, including maternal obesity,
gestational diabetes, preterm labor, increased risk of hemorrhage and anemia, and adverse
neonatal outcomes, including low birth weight and cerebral palsy (Cleland, Conde-Agudelo,
Peterson, Ross, & Tsui 2012; Conde-Agudelo & Belizán, 2000; Hanley, Hutcheon,
Kinniburgh, & Lee, 2017; World Health Organization, 2005; Zhu, 2005). For women living
with human immunodeficiency virus (HIV), pregnancy planning yields the additional and vital
benefit of optimizing maternal health and prevention of mother-to-child transmission of HIV
(Chersich et al., 2006; Wilcher & Cates, 2009). There is a dearth of literature on birth spacing
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in women living with HIV in the developed world. In this study, we conducted interviews with
inner-city multiparous women living with HIV to identify barriers and facilitators to
maintaining ideal inter-pregnancy intervals and to explore women’s attitudes towards and
experiences with dual method contraception.
Literature Review
Women who plan their pregnancies are more likely to remain adherent to medical
treatment for HIV during the inter-pregnancy interval, resulting in suppressed maternal HIV
viral load (the detectable level of the HIV virus in the maternal blood) and significantly
decreased risk of mother-to-child-transmission of HIV (Raifman et al., 2014). In the United
States (US), however, only one in six HIV positive women at risk of pregnancy reports current
use of long-acting reversible contraception, such as an intra-uterine device or progesterone
implant, which have been shown to be the most effective methods of unplanned pregnancy
prevention (Sun et al., 2012). The rate of unintended pregnancy in Washington, D.C. (DC) is
similar to the high national rate (58 v. 54 per 1,000 women aged 15 – 44; Kost, 2013). Rates
of unplanned pregnancy and birth in HIV positive women are high but tend to reflect local rates
in the uninfected population (Massad et al., 2004; Sutton, Patel, & Frazier, 2014). The rate of
unplanned births to African American women living below the federal poverty limit is sixtimes higher than of women with higher incomes, and twice that of non-Hispanic White women
(Finer & Zolna, 2014).
For people living with HIV seeking to avoid pregnancy, the World Health Organization
recommends dual method contraception—namely use of condoms to reduce the risks of HIV
and STI transmission along with an additional more effective birth control method to prevent
unwanted pregnancy (World Health Organization, 2015). Despite this recommendation, the
majority of women living with HIV in the US who do not seek pregnancy do not practice dual
method contraception (Massad et al., 2007; Wilson, Koenig, Walter, Fernandez, & Ethier,
2003), leaving them at risk for unplanned pregnancy and/or transmission of HIV and STIs.
Few investigators have explored trends in dual method contraceptive attitudes and
behaviors among these HIV positive women. Most recently, Haddad and colleagues used a
large US healthcare claims database to describe trends in prescription-based contraceptive use
in HIV positive women (Haddad et al., 2017). Of the 1,185 women they identified, only 28.9%
were linked to claims for prescription-based contraception, including short- or long-acting
reversible contraceptives and female sterilization. The remainder and majority could not be
linked to claims for these methods, which are the types most often used in addition to condoms.
Massad and colleagues (2007) analyzed 2,784 structured interviews conducted as part of a
multi-center prospective cohort study of women living with HIV, in order to describe trends in
contraceptive use. They found that over an 11-year period, HIV positive women chose
condoms (30.5 – 36.3%), followed by tubal ligation (21.8 – 26.5%), and then hormonal
contraceptives (<10%) as their preferred mode of birth control; the rate of intrauterine device
use remained steady at less than 5% per year (13). Wilson and colleagues (2003) interviewed
258 HIV positive women at 6-months postpartum to assess their attitudes and behaviors
towards dual use contraception; among women who reported at least one act of sexual
intercourse since childbirth, 86.6% reported condom use. They found that only 57.4% of HIV
positive women reported use of either female sterilization or hormonal contraceptives. When
Wilson compared women who were consistent dual users with inconsistent dual users, they
found that women in the former group were more highly motivated to avoid rapid repeat
pregnancy (OR 2.4, 95% CI 1.05 – 5.37). Chen, Phillips, Kanouse, Collins, and Miu (2001)
found that HIV positive women’s fertility desires and attitudes towards pregnancy can be
incongruous; 69% of the HIV positive women interviewed did not desire children in the future,
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however despite certainty in not wanting additional children, 27% would not choose to
terminate an unintended pregnancy.
Barriers and facilitators to birth spacing and dual contraception use among women
living with HIV in resource rich countries, such as the US, are poorly understood. Medical
providers must know the determinants of successful birth spacing and contraception use if they
are to facilitate planned pregnancy and reduce mother-to-child-transmission of HIV. The goal
of our study is to address this knowledge gap and to better understand HIV positive women’s
experiences with birth spacing and dual contraception.
The study was designed by Drs. Rachel Scott (R. S.) MD, MPH and Regina Zopf (R.
Z.) MD, obstetrician-gynecologists who provide prenatal and gynecologic care for women
living with HIV at an urban hospital in DC. Our research was born out of the desire of Drs.
Scott and Zopf to better understand the high rates of short-interval unintended pregnancy in
their HIV positive patient population. Patricia Tanjutco (P. T.) MD, a research coordinator with
several years’ experience working with women living with HIV, recruited patients from Drs.
Scott and Zopf’s clinic and conducted the patient interviews. Piyapa Praditpan (P. P.) MD, an
obstetrician-gynecology resident, and Elizabeth Laidlaw (E. L.), a Masters of Public Health –
Physician’s Assistant student, facilitated interviews and assisted with data analysis as part of
their medical research training. R. S. and R. Z. did not participate in interviews secondary to
concern that it would bias participants’ responses. Manon Schladen (M. S.) PhD, a qualitative
researcher working primarily with individuals from underserved, urban African-American
communities, consulted on study methodology and served as the primary qualitative analyst.
Dr. Schladen’s research focus over the past several years has been on crystalizing the patient
perspective to support health care that is increasingly patient-centered. The only non-clinician
on the study, Dr. Schladen brought the personal perspective of a multiparous woman with
equivocal experiences of contraception and birth spacing to provide counterpoint to the
research team.
Research Question
What are the barriers and facilitators of optimal birth spacing and dual contraception
use among underserved, urban women living with HIV in the United States?
Methods
Approval
This study received approval from the institutional review board for the medical center
where it took place.
Recruitment and Participants
For this study, we sought a convenience sample of patients who received outpatient
obstetric and/or gynecologic care at the major urban hospital in DC where R. S. and R. Z. are
in practice. Women who receive care at this institution are largely representative of our
population of interest: inner city, African American, and living below the federal poverty level.
Study personnel (R. S., P. T., E. L.) identified and recruited female patients living with HIV.
P. T. and E. L. reviewed patients’ demographic and medical information in the electronic
medical record to screen for eligibility. We included women who were of reproductive age (18
– 45 years), multiparous, HIV positive, and English-speaking. Patients meeting the inclusion
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criteria fell into two categories of interest: (1) those with inter-pregnancy intervals greater than
two years apart and (2) those with inter-pregnancy intervals less than two years apart.
Semi-Structured Interviews
After written informed consent was obtained, women participated in face-to-face,
individual or paired, semi-structured interviews (conducted and audio-recorded by P. T.). A
professional transcription service provided electronic transcripts the interview audio. We
designed interviews to take place within a 30-minute time window to make it feasible for our
patients to participate before or after their scheduled clinic appointments. The study team
conceived this approach to reduce potential burden on participants, for whom transportation
and family issues often create barriers to coming to the clinic. Women received a $50 gift card
and transportation reimbursement in appreciation of their participation. Interview questions
focused on women’s use of short-acting and long-acting reversible contraceptives and barriers
and facilitators of birth spacing. Beyond the initial screening done to establish eligibility, we
did not compare participants’ descriptions of their experiences with contraception or pregnancy
spacing to what may have been recorded in their medical records. Our intent was to give
primacy to how participants experienced and made sense of those phenomena.
Analytic Framework and Process
We adopted the broadly applicable framework described by Miles, Huberman, and
Saldaña (2014) to analyze participants’ interviews. The framework defines three major phases
of data analysis: data reduction, data display, and conclusion drawing and verification. Data
reduction is the iterative process of selecting and focusing data in relation to one’s research
questions. Data display may be graphical or text-based, but its essence is organization and
compression, characteristics that promote visualization of emerging themes and relationships.
Conclusion drawing and verification is the culmination of the research process and the phase
where the researcher interprets and ascribes meaning to the analyzed data.
The primary qualitative analyst (M. S.) used NVivo (version 10, qualitative data
analysis software; QSR International Pty Ltd, Docaster, VIC, Australia) (QRS International,
2015) to reduce the data, which consisted of participants’ interview audio files and transcripts.
She memoed the transcripts while listening to the audio of the interviews both as a verification
step and to capture non-explicit data (e.g., hesitation, tone of voice). Where she was in doubt
as to what was said or meant, M. S. consulted with the research team member(s) who had
conducted the interview in question. She first coded each transcript to the interview questions,
which were developed a priori and did not vary across interviews. M. S. subsequently engaged
in a continual, reflective process of iterative memoing, theme identification and exploration.
She kept a research journal to track how her understanding evolved over time as she
increasingly immersed herself in the interview data. Maintaining a reflective journal
throughout a study exposes the degree to which the researcher is able to bracket (Tufford &
Newman, 2010), transcend his/her personal biases, in qualitative analysis. Journaling is a best
practice that introduces transparency into the research process and enhances confirmability
(Trochim & Donnelly, 2008) and credibility (Morse, Barrett, Mayan, Olson, & Spiers, 2002)
of findings. Further, the process of making sense of qualitative data as it emerges is essential
to its coherence (Morse et al., 2002; Reigeluth & Frick, 1999). Because emergence is nonlinear, Morse et al. (2002) advocate a specific aim (reminiscent of quantitative approaches) of
“methodological coherence” in study designs. The function of methodological coherence is to
continually bring the researcher back to the question or questions guiding the study to promote
recognition that how the emerging data is taking shape may require revisiting earlier coded
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passages and exploring them in a new light. To promote methodological coherence, M. S.
adopted a deliberate practice of reflecting on whether each subsequent interview cast previous
ones in a different light and committing her thoughts to the journal.
M. S. developed a classification scheme based on themes and participant characteristics
to delineate the similarities and differences in participants’ experience of child spacing and
adherence to the dual method of birth control prescribed for persons who are HIV positive. The
scheme gave rise to the development of a series of displays to help visualize themes and trends
in women’s experience with dual method contraception and birth spacing.
The clinical research team (R. S., P. P., P. T., E. L.) reviewed the displays to verify,
question, or further explore the experiences and perceptions that M. S. saw in the data. After
discussion, M. S. used a trace-back approach to provide greater about which themes adhered
to which participants and to aid in drawing conclusions, the final step of the Miles, Huberman,
and Saldaña framework (2014). To protect their privacy, we assigned pseudonyms to all
women interviewed in the study and reviewed the data presented to assure that there was not
sufficient information provided about any individual to allow recognition. We did not create
composite profiles as we believed that the characteristics presented in each woman’s history
were relevant in understanding her experience of using dual method birth control and spacing
her children and contrasting it with that of other participants.
Results
Organization of Results
In presenting our results, we first provide an in-depth description of the women who
participated in interviews to familiarize the reader with the range of participants’ experiences
with pregnancy spacing and dual method contraception after HIV infection. We delineate
which women spaced their pregnancies at the prescribed interval and which had not done so to
point up individual differences in women’s experience that may help explain adherence and
non-adherence to recommended practices. Finally, we explore the major and minor themes that
emerged from interviews and which may help better understand the barriers and facilitators to
dual method contraception use and pregnancy spacing in underserved, urban women who are
HIV positive.
Interview Cohort Descriptive Statistics
Eighteen, HIV positive women participated in this study. Participants’ motherhood
experience ranged from four to 25 years. Cumulatively, they reported 65 children (Table 1).
Seven women were pregnant at the time of their interview. Their unborn children were included
in the total number of children (twins counted only once). Women reported birth-spacing
history in years, thus we used a conservative approach to differentiate between pregnancies
spaced at less than or greater than two-year (24-month) intervals. Unless specified, we counted
participants’ children as spaced less than two years apart if their difference in ages was reported
as two years. Women reported 13 pregnancies spaced ≤2 years apart and 34 pregnancies spaced
>2 years apart.
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Table 1. Descriptive Statistics on Participants (Self-report)
Total Number of Women Responding
18
Total Number of Living Children1 and Current 65
Pregnancies (twins counted once)
Range in Years of Motherhood
4 – 25
Total Inter-pregnancy intervals > 2-years
34
Total Inter-pregnancy intervals <= 2-years
13
Pregnant at Time of Interview
7
Child Spacing as Result of Not Being in a 4
Relationship or Stated Periodic Abstinence
Married Status Rationale for Choices
2
Attributed a Child (Unplanned) to Not Using 8
Birth Control
Experience with Long-term Birth Control Methods
Oral Contraceptive Pills (OCPs)
132
Depot medroxyprogesterone acetate (DMPA) 15
“Depo Provera”
Intrauterine device (IUD)
63
Implant
14
Patch
6
Ring
25
Tubal Ligation
36
Hysterectomy
17
Other
18
Experience with Condoms
Male Condoms
17
Female Condoms
1
These 18 HIV positive women fell into two, basic patterns of child spacing: Pattern A
≤2 years spacing for a woman’s older children, but >2 years spacing between her younger
children; Pattern B consistent spacing of children >2 years apart (Table 2)

Patterns

Women

1

A
B
≤-year spacing with older children, Consistent
>2-year
spacing
>2-year spacing with younger through
reproductive
years
children
Althea, Collette, Eve, Georgia, Bethany, Denise, Flo, Isabelle, Lisa,
Helen*, Joanne, Karen, Olivia, Quiana Marie, Noreen, Polly, Regina
*Consistent child spacing of ≤2 years

Some women alluded to perinatal deaths of children and having miscarriages but they did not elaborate on then.
These children/pregnancies are, therefore, not part of this tally unless the woman specifically included them in
her description of child spacing.
2
One additional woman considering OCPs
3
Two additional women considering IUDs
4
One additional woman considering an Implant
5
One additional woman considering the ring
6
Two additional women planning tubal ligations after delivery of current pregnancy
7
Not intended as birth control, performed due to complications after delivery
8
Lunelle (information volunteered)
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All women reported some experience with a birth control method. The majority (11)
reported prior use of two reversible methods of contraception. Four women reported experience
with three of these methods and two women reported use of four. All but one woman reported
experience with male condoms; one participant reported experience with female condoms. Of
hormonal contraceptives, most women (13) reported experience with Depo-Provera (depot
medroxyprogesterone acetate) followed by oral contraceptive pills. Less than half of women
(6) reported experience with the contraceptive patch and a couple reported experience with the
contraceptive ring. Less than half of the participants reported use of a long-acting reversible
contraceptive method; six had used an intrauterine device and one had used a progesterone
implant. Three women were using tubal ligation as contraception, while two others planned to
undergo this procedure after delivery of their current pregnancies.
Identified Themes
Five major and three minor themes emerged from analysis of women’s interviews. The
themes in this study are attitudes, experiences, or perceptions that have influenced more than
one woman’s actions with respect to using dual method contraception and spacing of
pregnancy.
Theme 1: Incomplete understanding of rationale behind recommendations for
pregnancy spacing and use of dual method birth control when HIV positive.
Women provided highly variable responses when asked what they considered to be the
“ideal” interval for pregnancy spacing after HIV (see figure 1). No woman recommended an
interval shorter than the recommended 24 months, but neither did any woman identify
prevention of mother-to-child transmission of HIV as a factor important in her decision-making
relative to pregnancy spacing. Maternal well-being was identified, but not with reference to the
special needs of maintaining health after HIV infection. Though all participants were living
with HIV, they uniformly re-focused the question, and provided reasons for child spacing that
might apply to women generally, rather than on the special health requirements relevant to HIV
positive women.

"Ideal" Pregnancy Spacing Intervals
3
2
1
0

Years between pregnancies

Figure 1. Participants’ assignment of ideal pregnancy spacing intervals
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Isabelle’s responses, with respect to her second and third pregnancies, may be
illustrative. Her focus is on issues of finances and independence from her family, not on the
risks inherent in her HIV-positive status.
Interviewer: What do you think is a good number of years to wait between
children?
Isabelle: In my opinion, I spaced my children. I had my 10-year-old when I just
turned 21. I was not really financially ready, I was still living at home with my
mom, and I waited until I got on my own to have my 3-year-old and I waited
again to have this baby…
Interviewer: So, what do you think is a good number of years to wait?
Isabelle: The space that I did, the 10 and 3.
Though they did not include the reference to personal practice “that I did” that Isabelle did,
most women endorsed the spacing of their own children as ideal. Women’s lack of focus on
the urgency of pregnancy spacing for prevention of mother-to-child-transmission of HIV may
be rooted in an overall sense of resentment, not wanting to be reminded of their HIV-positive
status that Flo expressed in a different context, noting that having to use condoms with one’s
husband was just a continual reminder of living under the specter of HIV.
We asked women who had longer inter-pregnancy intervals to describe what helped
them wait between pregnancies. Again, participants responded with reasons not related to their
HIV status. Rather than explaining the motivators and facilitators of birth spacing they
experienced as HIV positive women, they noted maternal physical recovery and the difficulty
of parenting many young children as motivators for child spacing. The follow two quotes are
typical.
Quiana: I say: you have to give your body basically a rest. You cannot keep
having babies. You are trying to mess you up. Every pregnancy is not the same.
Lisa: The age span is, like, you don't want to have ‘em back to back because of
the growing process. I done seen people have two babies, maybe three, in
pampers.
Four women further attributed longer spacing between their pregnancies to being out of a
relationship or abstinence from sexual relations. Again, neither of these situations takes HIV
into account.
Of the 18 women interviewed, 13 reported that they were aware of the recommendation
to practice “dual method” contraception after HIV. Three women were unaware of the meaning
of this contraceptive strategy. When discussing the use of condoms with a long-acting
reversible contraceptive, half of women stressed the importance of condoms for STI prevention
while half stressed their importance as back up to long-acting reversible contraception. Only
two women acknowledged condom use for both STI and pregnancy prevention. Regardless of
their ability to articulate awareness of the term “dual method” contraception, nine of the
participants described contraceptive practices consistent with this method, although half
expressed reservations about its efficacy.
Overall, understanding of the need to space pregnancies at 24 months or greater to
protect one’s child from HIV transmission appeared to be lacking, though women articulated
other, common sense reason for child spacing at that interval. Understanding of and
commitment to dual method contraception was likewise weak to absent. Women showed a
strong tendency to hold the special requirements of longer interval child spacing and use of
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dual method contraception apart from their thinking about family planning in general, casting
a veil of normalcy and personal choice over the patterns they reported.
The following theme (2) deals with locus of control, personal differences in action that
result from the perception of one’s power to act and make a change. These differences in
individuals’ perspectives did not clearly emerge in women’s demonstration of understanding
of the need for longer interval child spacing and use of dual method birth control after HIV.
Nor did these differences appear to impact our participants’ “drive to normalcy” when
questioned about ideal child spacing.
Theme 2: Successful pregnancy spacing and locus of control.
Individuals who exhibit a strong internal locus of control are likely to believe they have the
capacity to achieve a desired health outcome (Wallston, Osborn, Wagner, & Hilker, 2011).
Essentially, persons with a strong internal locus of control believe that they have control over
what happens in their lives. Conversely, persons with a strong external locus of control believe
that what happens to them is outside of their control. We observed that women whose child
spacing history conformed to Pattern B, spacing of pregnancies >2 years apart, expressed more
statements suggesting an internal locus of control than did Pattern A women, those with a
history of pregnancies spaced ≤ two-year intervals. Regina and Flo, both Pattern B child
spacers, provide examples of attitudes suggesting strong internal locus of control.
Regina: I do not feel good with the shot (Depot medroxyprogesterone acetate),
but I have to take it because I do not want to get pregnant.
Flo: I am thinking I could have a child that is negative, which I do. BOTH of
my kids are negative!
Regina is able to sublimate her issues with the Depot medroxyprogesterone acetate shot
because of her resolve to avoid pregnancy. She makes a decision and assumes control.
Likewise, Flo, knowing that if she follows the recommended medical regimen, she can prevent
HIV transmission to her children, resolves to follow the approved regimen. She presents the
results of her resolve with pride: neither of her children have HIV.
In contract, Georgia and Karen, Pattern A child spacers, evidence more passive
perspectives.
Georgia: Whatever God brings to you, it is a blessing. My children are a
blessing. The sickness that I have is only God, baby, believe me, that is a
blessing…
Karen: Stuff just happens, things just happen between you and your male
friend.
Georgia takes whatever life brings to her, believing that it is as it should be. Karen, likewise,
is comfortable with her belief that male-female relationships simply chart their own course.
The four women quoted here stood out in their demonstration of the poles of external/internal
locus of control in their descriptions of their experiences with HIV. Notably, other participants’
discourse presented more neutral perspectives.
Theme 3: The burden of contraception in HIV positive women.
The theme of the burdensomeness of contraception was ubiquitous across interviews.
Burden was associated with both long-acting reversible contraceptives and condom use.
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Women cited several known side effects of contraception as barriers to use. They are
summarized in the display provided in Table 3. Women reported fewer undesired side effects
with oral contraceptive pills than Depot medroxyprogesterone acetate injections. Two women,
however, described a sense of being overwhelmed by the prospect of taking oral contraceptive
pills in addition to their HIV medications. Of the six women who had used the patch, one
participant associated patch use with a history of stroke. Another participant reported that her
Intrauterine Device migrated outside of the uterus and required surgical removal.
Table 3. Reported side-effects with long-acting reversible contraceptives methods
Women
who
reported

Method

General
malaise

Weight
gain

Bloating

Nausea/GI
disturbance

15

Depot
medroxyprogester-one
acetate

1

10

3

13

Oral
contraceptive pill

6

Intra-uterine
device

6

Patch

2

Ring

1

1

Implant

1

2

Headache

1

Change in
menstruation

Pain

Hair loss

2

19

4

1

1

Other
physical
complaints

2

3

1

Althea: This is going to be kind of superficial to say, but a lot of the birth
controls now tend to put a little extra weight on you and so for that reason,
myself and a lot of other women do not want to use it.
Althea identifies distaste for putting on extra weight as “superficial,” not equal to the greater
good of optimal child spacing. At the same time, however, she reveals insult to a women’s selfimage as a potent disincentive to contraception use.

Pain at injection site
Extrauterine migration necessitated surgical removal
11
Informant reported stroke
10

110

111

The potential impact of certain hormonal contraceptive side effects on women’s selfimage was also a barrier to use, specifically with short-acting reversible contraceptives,
including oral contraceptive pills and Depot medroxyprogesterone acetate. Participants
described fear of weight gain and hair loss as problems with consistent use of these methods.
One participant shared the following:

9

Serious
medical
complications
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Multiple women identified adherence to short-acting reversible contraceptives as a
barrier to ideal pregnancy spacing. Nine women stated that adherence to daily dosing of oral
contraceptive pills and routine maintenance of clinic appointments for Depot
medroxyprogesterone acetate injections were barriers to successful use of these methods. Four
women discussed the “intrusiveness” or “unnaturalness” of condoms as well as lack of
cooperation from partners with use. One participant reported adherence to condom use,
however described doing so as an undesired reminder of her HIV positive status.
In summation, burden emerged as a multi-faceted theme from women’s interviews. It
included long-acting reversible contraception side effects, those causing women to feel
physically unwell and also those impacting their self-image, such as weight gain and hair loss.
It also included distaste for the disruption of the natural flow of sexual relations due to required
condom use and the continual reminder of one’s HIV positive status that condom use inflicted.
Theme 4: Failure of birth control in women living with HIV.
Our interviews yielded numerous definitions of “birth control failure.” Women who
reported experience with hormonal short-acting reversible contraceptives defined failure as the
experience of an unplanned pregnancy. Other women referred to Intrauterine Device migration
and male condom breakage as method failure, whether or not these resulted in unplanned
pregnancy.
Women with both patterns A (children spaced at ≤2 years) and B (children spaced at
>2 years), of child spacing experienced birth control failure. They reported failure to adhere to
their chosen method as well as device failure. Four of the six women who had used Intrauterine
Devices, reported device failure. Women who adopted Pattern B birth spacing reported
experience with a greater variety of long-acting reversible contraceptive methods and twice the
number of birth control failure descriptions as women who adopted Pattern A birth spacing
(Table 4). Eight women explicitly attributed an unplanned pregnancy to not using birth control.
Table 4. Self-reported failure12 of birth control methods
RED= Pattern B; BLUE= Patterns A
Method/

Failure Reasonably

Failure Related to

Failure Mentioned,

Reports

Related to Method

Improper Use

Circumstances Not

Failure Itself
Depot
medroxyprogesterone
acetate (3)

Elaborated
● Georgia: “I think that ● Polly: “I was on …
issue, because I had
the shot and I got
missed a month and I
pregnant …”
went back to go get the
shot.”
● Helen: “I was taking
Depo for a second and
then I stopped. It

“Failure,” when used in conjunction with methods more readily controlled by the woman, e.g., OCPs, Depo,
the patch and the ring, signifies that an unplanned pregnancy occurred. In these cases, the woman’s indication that
the method has failed is pregnancy. “Failure,” when used in conjunction with methods less likely to be under a
woman’s direct manipulation, e.g., the IUD and male condoms, includes migration (IUD) and breakage (condom)
with or without accompanying incidence of unplanned pregnancy. In these incidences, it is obvious that the
method isn’t doing what it’s supposed to do without a pregnancy having to occur.
12
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seemed like as soon as I
stopped, I got pregnant.”
Oral
Contraceptive

● Polly: “I just forgot
…and I got pregnant.”

Pills (OCPs)
(1)
Intrauterine ● Bethany: “I had it for
two years …I just got
Device (IUD)
pregnant while I was
(4)
on it.”
● Collette: “Actually,
after I had my daughter
I tried a new form of
birth control, which
was the IUD. I got
pregnant with the IUD
still inserted with my
son. I was in the low
percentile of that
possibility of
happening.”
● Eve: “The only
problem I had was it
fell out.”
● Flo: “The Mirena, they
had to surgically
remove it because it
came out of my uterus
and wrapped around
my intestine.”
Patch (3)
● Noreen: Same thing (as● Bethany: “I got
the NuvaRing, e.g.,
pregnant with my
stopped using it due to
oldest.”
confusion).
● Karen: “(I) didn’t know
it wasn’t working.”
Ring (1)
● Noreen: “That was my
fault with the NuvaRing
because I thought after I
go off I was supposed to
put it on, but I was
supposed to wait exactly
seven days then pull it,
so I just stopped taking
it.”
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Condoms,
Male (6)

● Polly: “It broke, that is●
why I use two.”
● Noreen: “It broke.”
● Quiana: “No
challenges, except for
the breaking.”

Noreen: “The father felt●
a little bit happier about
himself, got a bigger
size than what he
needed. It came off.
That is how I got my
little girl.”
● Georgia: “I just hate
that part when you just
get it stuck in you.”
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Regina: “No, I have
had no problem with
condoms. Well, yes
one time my last
baby's father. That is
why I got pregnant.”

The experience of birth control failure, both failure of the method/device itself and
failure related to proper use, was reported by both women who spaced their children at >2 year
intervals and those who did not. That long birth spacers explored more methods of birth control
than did short spacers may be significant and related to a possible greater tendency toward
internal locus of control.
Theme 5: The impact of youth and lack of life experience.
All of the participants cited youth and lack of life experience as barriers to ideal
pregnancy spacing. Two women with Pattern A birth spacing cast their own, youthful failures
in recommended child spacing in that light.
Olivia: My oldest ones, with them I just got pregnant. With the first three kids
I got pregnant, I was young. You know, at 21 I had three kids, so I was just
humping. Honestly, that is the truth in that. … With the last two, it was different.
Georgia: I was young. I was young when I had them. I was 18 and 19 when I
had them.
Both Olivia and Georgia attribute their inability to space their early pregnancies to youthful
nescience. Interestingly, their later children were spaced at the recommended >2-year interval.
Some women related the degree of parental guidance they received as youths to
prevention of HIV infection and pregnancy planning. Isabelle lamented that her mother had
provided her no guidance at all and she was left to learn from her sad experiences.
Isabelle: As females, we have daughters and when they get of age, you should
be talking to them. My mother didn't talk to me. I had to find out the hard way.
Flo, likewise, endorsed parental involvement, even the intimidating engagement modeled by
her mother.
Flo: It was different for me because my mother, she kind of scared me too. She
scared me half to death, so I did not have sex until I was 18, but she scared me
half to death and everything. She would go into the doctor's office. I went right
over there to the adolescent clinic, I had Dr. Smith (pseudonym) and she would
ask her, “Make sure her hymen is still there.” My mother was just in the room
and wanted to know. Even though I told her, "I am still a virgin, mom," she did
not believe me.
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Georgia, on the other hand, recognizes that there is only so much a parent can do given the
freedom of choice that adolescents increasingly have.
Georgia: Nowadays there are little girls of age, because I have a 16-year-old,
and I can want for her all day to have some type of birth control, but she has to
want to have it. In other words, if she says no, the doctor cannot give her
something that she is refusing and I do not think that is fair, as a parent. …I
mean, we can encourage, but today's society, these young girls they are running
wild rapidly and some parents are not even paying attention to most children
and that is pretty much how a lot of things are happening, but, like I said again,
my daughter is 16. I went to (the hospital clinic). I wanted her to have the Depo.
If she refuses it, I cannot go in the room with her, they cannot tell me if she has
sex. I think that is very emotional for me because I am a mother with HIV.
In the absence of parental guidance, women endorsed schools and health clinics as important
surrogates. Generally, women agreed that teaching should occur in a realm of authority like the
health clinic, school, or home. They also acknowledged that media played an important role in
sexual and reproductive health education.
Olivia: I always say it (education about sexuality) should start in your home,
but I think it needs to be exposed more in schools and they really need to start
it in elementary honestly. It is out of control. You would be surprised what these
young girls ask, these questions and stuff they know at 12 and 13, and this is
stuff
that
their
parents
do
not
know.
Regina: Educate them more so they can pick (condoms) up, because some
young girls do not like using them and they do not pick them up. … They are
not educated at all about using condoms. They think that having sex is okay
with that person without using a condom … I think educating them more when
they come in the clinic and talking to them and letting them know it is good to
use condoms, do not be ashamed to use condoms so you will not catch anything!
Women identified youth and lack of guidance as a significant problem in responsible sexuality.
Here, as in much participants’ narrative, the line blurs between generally responsible behavior
and the stricter behaviors that are necessary after HIV infection.
Theme 6 (Minor): Community beliefs about birth control.
Participants expressed skepticism about the efficacy of birth control, regardless of
adopted pattern of birth spacing. Lack of confidence in the efficacy of dual method birth control
was rooted in a personal sense of its burden and sustained by peers’ anecdotes of birth control
failure.
Isabelle: I hate (dual method contraception). The condoms are for protection
against HIV and other sexually transmitted diseases, which I agree. The birth
control is just to stop the pregnancy, but birth control is not always accurate.
Because I have heard some of my female friends say they got pregnant on their
shot. They got pregnant on the IUD (Intrauterine Device).
Polly: No … you end up pregnant just like, I know a young lady she got that
thing up in her thing and she got that and got pregnant.
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Community beliefs and experiences of birth control failure like those expressed in the peer
anecdotes shared by Isabelle and Polly appear to significantly influence participants’ opinions
of contraceptive efficacy and decision-making regarding their use.
Theme 7 (Minor): Lack of partner cooperation with family planning in
reproductive aged women living with HIV.
In addition to youth and contraceptive failure, several women reported lack of partner
cooperation as a barrier to family planning and pregnancy spacing. Several women reported
that lack of cooperation with condom use from sexual partners is common. Quiana described
intentional sabotage by former partners:
Quiana: Sometimes they will put a hole in it or then wait until the last minute
and tell you.
Interviewer: Intentionally put a hole in it?
Quiana: Yes, they will if you are not paying attention and watching them. They
will put a little hole in it and whatever. That happened to me plenty of times.
Isabelle recounts lack of cooperation as well, but with a somewhat different tone.
Isabelle: You are going to put it on (a condom). If you don't put it on, you're
not getting nothing.
Quiana and Isabelle describe the same reluctance of their partners to use condoms. Their
attitudes and responses are different, however. Quiana is the victim of deception whereas
Isabelle enforces her rule about condom use. Interestingly, Quiana is a Pattern A child spacer
and Isabelle, a Pattern B. In this case as in earlier cases, the Pattern B spacer shows stronger
internal locus of control than does the Pattern A spacer.
Theme 8 (Minor): Altruism and contraception in women living with HIV.
Altruism, expressed as the desire to reduce the risk of partner and mother-to-child
transmission of HIV barely emerged as a motivator for adherence to dual method
contraception. It was present most palpably in Isabelle’s recounting of condom use with her
partner.
Isabelle: I use condoms now with my partner, even though I'm pregnant. There
is still a slight chance he could still catch HIV, so we have been using condoms.
… I feel that since I got infected with HIV seven years ago, before that I didn't
care. I didn't give a man a choice to put on a condom, but now since I've been
infected and since I've been more careful, I have a choice now.
Isabelle recounts how her priorities have changed since she has been HIV positive. She didn’t
offer her partners a condom before she was infected, but now, in consideration of his wellbeing, she does. Consideration, altruism toward her partner, provides a motivation to adhere to
condom use.
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Discussion
Although a recent large retrospective review called into question the causality of short
interpregnancy intervals on several previously attributed adverse pregnancy outcomes, there
do appear to be clear maternal and neonatal benefits to birth spacing (Hanley et al., 2017). For
women living with HIV, the opportunity to optimize HIV status through planned pregnancy
and ideal birth spacing can yield significant benefits to maternal and neonatal health (Chersich
et al., 2006; Raifman et al., 2014; Wilcher & Cates, 2009).
The vast majority of our study participants reported male condom use for protection
against both unplanned pregnancy and HIV transmission. Even so, women’s narratives
described the challenges of consistent condom use. Women cited unnaturalness, difficulties
with partner cooperation, and anecdotes of condom failure (e.g., popping, slipping off) as
factors impeding consistent use. Their narratives also conveyed a sense of fatalism regarding
the inevitability of product malfunction and development of interpersonal tension.
Though reports of both anecdotes and personal experience with condom failure were
largely universal among interview participants, their decisions relative to adherence to condom
use was not. Personal factors that may relate to individuals’ locus of control emerge from their
narratives. This hypothesis is consistent with the findings of Wallston and colleagues, who
demonstrated the validity of the construct of locus of control/self-efficacy as measured by the
Perceived Medical Condition Self-Management Scale (PMCSMS) in HIV positive patients
(Wallston et al., 2011).
Our findings of low uptake of highly effective contraception among HIV positive
women susceptible to rapid repeat high-risk pregnancy is consistent with Wilson and
colleagues’ findings (2003) of relatively low utilization of hormonal contraception and
sterilization. Similarly, the incongruity described by Chen et al. (2001) is also reflected in our
small sample of HIV positive women. The theme of the burden of contraception permeates our
participants’ experiences and may account for reduced condom use. Our participants’
narratives suggest belief in one’s ability to achieve a goal may be a critical component to
consistent use of condoms with highly effective contraceptives. We observed that strong
feelings accompany fertility, childrearing, relationships with life partners and sexual partners,
and HIV positive status. Women from our small sample underscore the need for personalized
counseling regarding contraception and family planning.
Pregnancy spacing and prevention of HIV transmission is an exercise in health care
self-management. The physician prescribes the birth control method, but with short-acting
reversible contraceptives, the individual woman must implement its use. Our study suggests
that provider awareness of women’s reproductive plan and sociocultural contexts of her life are
essential to helping her select and remain adherent to an effective form of birth control.
Additional research on locus of control and self-efficacy with dual method contraception in the
setting of HIV, utilizing a validated measure such as Perceived Medical Condition SelfManagement Scale (PMCSMS) would likely offer additional insight into contraceptive choices
and pregnancy spacing.
The limitations of the analysis include those inherent in single-encounter semistructured interview research—understanding is emergent, so questions that arise in later
interviews cannot be readdressed to participants who completed their interviews. Similarly,
one cannot re-interview women to assess whether they agree with the conclusions we reached.
In addition, some women answered at length while others provided terse responses. Therefore,
our analysis is more heavily weighted to responses from the former group.
Our analysis is limited by the small sample of women from a single, inner city hospital
from a single geographical area. This said, our findings are likely generalizable to the many of
women living with HIV in urban areas of the US. Due to the recruitment environment of a
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single hospital program, sensitive nature of HIV, and privacy considerations embedded in the
consent agreement with participants (e.g., the risk that the narrative of one participant who only
agreed to participate individually might be identifiable to another participant), there was no
formal member-checking (i.e., explicit validation of themes or conclusions drawn in this report
by participants). Lastly, participants’ responses regarding their contraceptive experiences over
a lifetime are affected by recall bias. Several women alluded to the influence of HIV on their
contraceptive choices, however none clearly differentiated between practices before and after
diagnosis. We did not enquire about differences in contraceptive practices before and after HIV
diagnosis directly, a further limitation.
Implications of Our Research for Clinical Practice, Policy, and Further Research
Our study demonstrates that inner city, women living with HIV of childbearing age
may not have an articulable understanding of the precautions they need to take to protect their
sexual and reproductive health, that of their sexual partners, or of the implications for future
pregnancies. Practitioners should take great care to make sure patients living with HIV have a
comprehensive understanding of the contraceptive and reproductive health recommendations
for planned pregnancy/pregnancy prevention and prevention of HIV and STIs. From our
participants’ accounts, instruction at home was seen as primary, though the variability in home
situations was also pointed up as a problem in transmission of knowledge about reproductive
health behaviors after HIV. There is an unmet need for additional and improved reproductive
health education for women particularly among at-risk underserved urban populations both in
schools from early years and through Public Health programming such as wide-reaching social
marketing campaigns.
Beyond patients’ understanding, practitioners may want to consider the issue of trust
and credibility in how their patients will put recommendations into practice. Our participants
demonstrated the power that perspectives and anecdotal information coming from their
communities had on their behavior. This trust gap suggests that practitioners reflect on what
they do to build relationships with their patients. Our participants with HIV showed us that,
even though they came to our clinic faithfully, they did not necessarily believe or act on our
recommendations for health-preserving reproductive activity.
Clinicians may also want to recognize and address the equivocal nature of
contraception: that it brings a desired goal (healthy child spacing, prevention of disease
transmission) on the back of practice that creates burden. Many of our participants did not feel
well as a result of using long-acting reversible contraceptives. Use of long-acting reversible
contraception often caused discouraging body changes such as hair loss and weight gain.
Adherence to short and long-acting reversible contraceptives required discipline in terms of
remembering to take pills and make arrangements (scheduling, transportation, etc.) for clinic
appointments. Use of condoms to prevent disease transmission also interfere with the natural
flow of sexual relations and, in the case of a woman with HIV, bring her back to the conscious
realization of her status, a memory she may prefer to avoid. Addressing the burden of
maintaining healthy reproductive practices after HIV may require more support than can be
provided in typical clinic visits. At the policy level, clinics may consider how they might
implement more personalized inquiry and follow-up to find out how individual women are
coping with their prescribed contraceptive regimens.
Lastly, our study suggests that personal factors, such as internal versus external locus
of control, may play a key role in individuals’ ability to plan to use dual method contraception
after HIV and to adhere to the plan once in place. Further research in this area is recommended.
The women living with HIV who participated in our study viewed dual method
contraception favorably. However, these women also discussed significant barriers to
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contraceptive adherence, including side effects, lack of partner cooperation, and perceived risk
of contraceptive failure. Prevention of HIV transmission during pregnancy and to partners as
well as the need for maternal recuperation between pregnancies were identified as motivators.
Additional research and outreach is needed to address continued barriers to pregnancy planning
in women living with HIV.
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